Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile

被引:29
作者
Lis, Raphael [1 ]
Touboul, Cyril [1 ]
Halabi, Najeeb M. [1 ]
Madduri, Abishek Sainath [2 ]
Querleu, Denis [3 ]
Mezey, Jason [2 ]
Malek, Joel A. [4 ]
Suhre, Karsten [5 ]
Rafii, Arash [1 ,2 ,6 ]
机构
[1] Qatar Fdn, Weill Cornell Med Coll Qatar WCMC Q, Dept Genet Med & Obstet & Gynecol, Stem Cell & Microenvironm Lab, Doha, Qatar
[2] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA
[3] Inst Claudius Regaud, F-31052 Toulouse, France
[4] Qatar Fdn, Weill Cornell Med Coll Qatar WCMC Q, Genom Core, Doha, Qatar
[5] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA
[6] CHU, Hosp Arnaud de Villeneuve, Dept Gynecol Surg, Montpellier, France
关键词
Ovarian cancer; Mesenchymal stem cell; Transcriptome; Genomic modification; Metastasis; STEM-CELLS; TUMOR PROGRESSION; EXPRESSION; FIBRONECTIN; SPARC; ACTIVATION; INHIBITION; DOCETAXEL; NETWORK; LEADS;
D O I
10.1186/1479-5876-12-59
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The cross talk between the stroma and cancer cells plays a major role in phenotypic modulation. During peritoneal carcinomatosis ovarian cancer cells interact with mesenchymal stem cells (MSC) resulting in increased metastatic ability. Understanding the transcriptomic changes underlying the phenotypic modulation will allow identification of key genes to target. However in the context of personalized medicine we must consider inter and intra tumoral heterogeneity. In this study we used a pathway-based approach to illustrate the role of cell line background in transcriptomic modification during a cross talk with MSC. Methods: We used two ovarian cancer cell lines as a surrogate for different ovarian cancer subtypes: OVCAR3 for an epithelial and SKOV3 for a mesenchymal subtype. We co-cultured them with MSCs. Genome wide gene expression was determined after cell sorting. Ingenuity pathway analysis was used to decipher the cell specific transcriptomic changes related to different pro-metastatic traits (Adherence, migration, invasion, proliferation and chemoresistance). Results: We demonstrate that co-culture of ovarian cancer cells in direct cellular contact with MSCs induces broad transcriptomic changes related to enhance metastatic ability. Genes related to cellular adhesion, invasion, migration, proliferation and chemoresistance were enriched under these experimental conditions. Network analysis of differentially expressed genes clearly shows a cell type specific pattern. Conclusion: The contact with the mesenchymal niche increase metastatic initiation and expansion through cancer cells' transcriptome modification dependent of the cellular subtype. Personalized medicine strategy might benefit from network analysis revealing the subtype specific nodes to target to disrupt acquired pro-metastatic profile.
引用
收藏
页数:12
相关论文
共 42 条
[31]   Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation [J].
Schwarz, Roderich E. ;
Awasthi, Niranjan ;
Konduri, Srivani ;
Caldwell, Lauren ;
Cafasso, Danielle ;
Schwarz, Margaret A. .
CANCER BIOLOGY & THERAPY, 2010, 9 (08) :632-639
[32]   Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis [J].
Sher, Ifat ;
Adham, Sirin A. ;
Petrik, James ;
Coomber, Brenda L. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) :553-561
[33]   Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression [J].
Spaeth, Erika L. ;
Dembinski, Jennifer L. ;
Sasser, A. Kate ;
Watson, Keri ;
Klopp, Ann ;
Hall, Brett ;
Andreeff, Michael ;
Marini, Frank .
PLOS ONE, 2009, 4 (04)
[34]   Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity [J].
Strauss, Robert ;
Li, Zong-Yi ;
Liu, Ying ;
Beyer, Ines ;
Persson, Jonas ;
Sova, Pavel ;
Moeller, Thomas ;
Pesonen, Sari ;
Hemminki, Akseli ;
Hamerlik, Petra ;
Drescher, Charles ;
Urban, Nicole ;
Bartek, Jiri ;
Lieber, Andre .
PLOS ONE, 2011, 6 (01)
[35]  
Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO
[36]  
2-W
[37]   SPARC in cancer biology: Its role in cancer progression and potential for therapy [J].
Tai, Isabella T. ;
Tang, Michelle J. .
DRUG RESISTANCE UPDATES, 2008, 11 (06) :231-246
[38]   Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model [J].
Touboul, Cyril ;
Lis, Raphael ;
Al Farsi, Halema ;
Raynaud, Christophe M. ;
Warfa, Mohamed ;
Althawadi, Hamda ;
Mery, Eliane ;
Mirshahi, Massoud ;
Rafii, Arash .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[39]   Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells [J].
Xing, Hui ;
Weng, Danhui ;
Chen, Gang ;
Tao, Wenming ;
Zhu, Tao ;
Yang, Xiaokui ;
Meng, Li ;
Wang, Shixuan ;
Lu, Yunping ;
Ma, Ding .
CANCER LETTERS, 2008, 261 (01) :108-119
[40]   Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway [J].
Xing, Hui ;
Cao, Yang ;
Weng, Danhui ;
Tao, Wenming ;
Song, Xiaohong ;
Wang, Wei ;
Meng, Li ;
Xu, Gang ;
Zhou, Jianfeng ;
Wang, Shixuan ;
Ma, Ding .
APOPTOSIS, 2008, 13 (02) :213-223